Decipher Labs P/E Ratio
Decipher Labs (DECIPHER) P/E ratio is not applicable — EPS (TTM) ₹-3.05, 1 consecutive loss quarter. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Consecutive Loss Quarters: 1
Current EPS: ₹-3.05
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -0.35 | 0 | Loss |
| Sept 2025 | 0.02 | 0 | Profit |
| Mar 2025 | -4.07 | -4 | Loss |
| Jun 2025 | -3.39 | -3 | Loss |
| Dec 2025 | -0.53 | -1 | Loss |
| Sept 2024 | -1.31 | -1 | Loss |
| Mar 2024 | 1.19 | 1 | Profit |
| Jun 2024 | 0.94 | 1 | Profit |
Healthcare Peers with Valid P/E Ratios — DECIPHER Comparison
Healthcare sector average P/E 55.56, median 31.31 — DECIPHER excluded (negative EPS).
Sector Average PE
55.56
Sector Median PE
31.31
Lowest PE
2.86
Profitable Companies
195
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.61 | ₹64 | Low |
| Sunrest Lifescience | SUNREST | 3.82 | ₹31 | Low |
| Shelter Pharma | SHELTER | 4.69 | ₹43 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.76 | ₹7,399 | Low |
| JFL Life Sciences | JFLLIFE | 5.46 | ₹72 | Low |
| Dipna Pharmachem | DPL | 5.78 | ₹15 | Low |
| Mono Pharmacare | MONOPHARMA | 5.82 | ₹18 | Low |
| Amwill Health Care | AMWILL | 7.15 | ₹82 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹90 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Decipher Labs share price screener.
- Read Decipher Labs dividend payments for the complete payout history and dividend yield track record.
- See DECIPHER price to book ratio to compare market price against book value per share.